The article in this week’s edition of New Scientist is an amazing article, which is a summary of the clinical trial of conducted in Australia on both the link between Multiple Sclerosis and the Epstein-Barr virus, the virus responsible for glandular fever.
More importantly, early trails suggest that T-cell therapy can be a viable treatment for this auto-immune, but severely debilitating disease.
Amazing stuff and a must read.
Want to know more?
If you want more information or would like to book for a FREE full body assessment with one of our Physiotherapists or Exercise Physiologists, call us on 9857 0644 or email us at admin@md-health.websitepro.hosting
MS symptoms improved by treatment that attacks glandular fever virus
MS symptoms improved by treatment that attacks glandular fever virus
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis
Epstein-Barr virus–specific T cell therapy for progressive multiple sclerosis.
Multiple sclerosis (MS) is a chronic inflammatory disease of the CNS characterized by progressive demyelination and disability.